Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$294M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$293M |
| 3 |
WLL
Whiting Petroleum Corporation
WLL
|
+$213M |
| 4 |
Xcel Energy
XEL
|
+$178M |
| 5 |
McDonald's
MCD
|
+$173M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHI
Baker Hughes
BHI
|
+$255M |
| 2 |
Exelon
EXC
|
+$209M |
| 3 |
AbbVie
ABBV
|
+$199M |
| 4 |
CenterPoint Energy
CNP
|
+$130M |
| 5 |
American Electric Power
AEP
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.56% |
| 2 | Miscellaneous | 13.34% |
| 3 | Energy | 13.05% |
| 4 | Financials | 9.97% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FL
2226
CALL
DELISTED
Foot Locker
FL
| $1.44M | ﹤0.01% |
25,600
+22,000
| +611% | +$1.22M |
|
2227
PUT
Puma Biotechnology
PBYI
$473M
| $1.44M | ﹤0.01% |
+7,600
| New | +$1.69M |
|
|
CALL
2228
DELISTED
magicJack VocalTec Ltd
CALL
| $1.44M | ﹤0.01% |
176,991
-33,286
| -16% | -$287K |
|
2229
Franco-Nevada
FNV
$52.5B
| $1.43M | ﹤0.01% |
29,126
-213,397
| -88% | -$10.8M |
|
2230
iShares TIPS Bond ETF
TIP
$15.1B
| $1.43M | ﹤0.01% |
12,785
+8,752
| +217% | +$988K |
|
2231
Celldex Therapeutics
CLDX
$3.2B
| $1.43M | ﹤0.01% |
5,218
+4,498
| +625% | +$1.12M |
|
2232
First Commonwealth Financial
FCF
$2.09B
| $1.43M | ﹤0.01% |
154,834
+140,866
| +1,008% | +$1.27M |
|
|
GLBR
2233
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $1.42M | ﹤0.01% |
8,579
+7,953
| +1,270% | +$1.3M |
|
2234
iShares Core S&P Mid-Cap ETF
IJH
$126B
| $1.42M | ﹤0.01% |
49,015
-71,870
| -59% | -$2.02M |
|
2235
Ingles Markets
IMKTA
$1.57B
| $1.42M | ﹤0.01% |
38,269
+23,973
| +168% | +$674K |
|
|
RFP
2236
DELISTED
Resolute Forest Products Inc.
RFP
| $1.42M | ﹤0.01% |
80,596
+65,101
| +420% | +$1.14M |
|
2237
PUT
Freeport-McMoran
FCX
$114B
| $1.42M | ﹤0.01% |
+60,700
| New | +$1.68M |
|
2238
PUT
Vale
VALE
$64.7B
| $1.42M | ﹤0.01% |
+173,300
| New | +$1.62M |
|
|
ENDP
2239
DELISTED
Endo International plc
ENDP
| $1.41M | ﹤0.01% |
19,600
-91,856
| -82% | -$6.29M |
|
2240
PUT
ConocoPhillips
COP
$154B
| $1.41M | ﹤0.01% |
+20,400
| New | +$1.42M |
|
2241
CALL
General Mills
GIS
$21.6B
| $1.41M | ﹤0.01% |
26,400
-11,300
| -30% | -$584K |
|
|
TEP
2242
DELISTED
Tallgrass Energy Partners, LP
TEP
| $1.41M | ﹤0.01% |
31,500
-68,500
| -69% | -$2.88M |
|
2243
CALL
Trip.com Group
TCOM
$28.2B
| $1.41M | ﹤0.01% |
61,800
-10,200
| -14% | -$267K |
|
2244
CALL
UBS Group
UBS
$167B
| $1.41M | ﹤0.01% |
+85,000
| New | +$1.46M |
|
2245
Acadia Pharmaceuticals
ACAD
$5.1B
| $1.4M | ﹤0.01% |
44,110
+16,841
| +62% | +$478K |
|
|
PTX
2246
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $1.4M | ﹤0.01% |
14,907
-13,681
| -48% | -$1.31M |
|
2247
Commercial Metals
CMC
$7.54B
| $1.4M | ﹤0.01% |
85,793
-1,103,211
| -93% | -$17.9M |
|
|
NSTG
2248
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.39M | ﹤0.01% |
100,000
| – | – |
|
2249
CALL
Healthpeak Properties
DOC
$14.7B
| $1.39M | ﹤0.01% |
34,697
-16,580
| -32% | -$658K |
|
2250
Rambus
RMBS
$9.79B
| $1.39M | ﹤0.01% |
125,335
+1,197
| +1% | +$13.6K |
|
Similar funds
Israel Englander's Q4 2014 Portfolio in Review
As of Q4 2014, Israel Englander held 4,655 positions worth $47.2B, up 19% from $39.5B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Israel Englander deployed $7.42B of net new capital in Q4 2014, opening 1,009 new positions and adding to 1,528 existing holdings. Its largest new stake was Coca-Cola: 2,223,712 shares worth $93.9M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Baker Hughes, an estimated $255M trimmed.
- Israel Englander's largest Q4 2014 buy was Coca-Cola: 2,223,712 shares worth $93.9M.
- Israel Englander added most to CAMERON INTERNATIONAL CORPORATION in Q4 2014, an estimated $294M increase.
- Israel Englander's biggest Q4 2014 reduction was Baker Hughes, cutting an estimated $255M.
- Israel Englander fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $69M.
- Israel Englander's ten largest holdings make up 9.1% of its $47.2B portfolio in Q4 2014.
- Israel Englander opened 1,009 new positions and closed 792 in Q4 2014.
- Israel Englander's portfolio value rose 19% quarter-over-quarter to $47.2B.
Based on Millennium Management's 13F filing for Q4 2014, filed 17 Feb 2015.